Kurita Tadayoshi, Morita Koji, Sato Shigehito
Department of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
J Clin Monit Comput. 2015 Dec;29(6):779-88. doi: 10.1007/s10877-015-9667-x. Epub 2015 Feb 10.
β blockers reduce cerebral oxygenation after acute hemodilution and may contribute to the incidence of stroke when used perioperatively. The goal of the study was to investigate whether cerebral tissue oxygenation using near infrared spectroscopy can detect the β blocker-induced decrease in cerebral oxygenation depending on the severity of hemodilution and/or the dose of β blockers. Animals were anesthetized with 2% isoflurane and randomly assigned to a landiolol or esmolol group. After baseline measurement, landiolol or esmolol was administered at 40 µg/kg/min for 20 min, increased to 200 µg/kg/min for 20 min, and then stopped. Hemodynamic and arterial variables and the tissue oxygenation index (TOI) were recorded at each β blocker dose. Two stages of hemodilution were sequentially induced by repeated hemorrhage of 600 ml (33% of estimated blood volume) and infusion of the same volume of hydroxyethylstarch. During each stage, landiolol or esmolol was similarly administered and measurements were made. Landiolol and esmolol both dose-dependently decreased heart rate, mean arterial pressure and cardiac output, depending on the severity of hemodilution. Landiolol at 40 µg/kg/min was almost equivalent in potency to 200 µg/kg/min esmolol for decreasing HR before hemodilution. Based on the TOI, short-acting β blockers reduced cerebral oxygenation in a dose-dependent manner during hemodilution, and oxygenation returned to the baseline level after drug infusion was stopped. TOI may be useful for identification of a decrease in cerebral oxygenation for patients receiving β blockade during surgery associated with major bleeding.
β受体阻滞剂在急性血液稀释后会降低脑氧合,并且在围手术期使用时可能会增加中风的发生率。本研究的目的是探讨使用近红外光谱法测量脑组织氧合是否能够检测到β受体阻滞剂引起的脑氧合降低,这取决于血液稀释的程度和/或β受体阻滞剂的剂量。动物用2%异氟醚麻醉,并随机分为兰地洛尔组或艾司洛尔组。在基线测量后,以40μg/kg/min的速度静脉输注兰地洛尔或艾司洛尔20分钟,然后增加至200μg/kg/min再输注20分钟,之后停止输注。在每个β受体阻滞剂剂量下记录血流动力学和动脉参数以及组织氧合指数(TOI)。通过重复出血600ml(估计血容量的33%)并输注相同体积的羟乙基淀粉,依次诱导两个阶段的血液稀释。在每个阶段,同样给予兰地洛尔或艾司洛尔并进行测量。兰地洛尔和艾司洛尔均剂量依赖性地降低心率、平均动脉压和心输出量,这取决于血液稀释的程度。在血液稀释前,40μg/kg/min的兰地洛尔降低心率的效力几乎等同于200μg/kg/min的艾司洛尔。基于TOI,短效β受体阻滞剂在血液稀释期间以剂量依赖性方式降低脑氧合,并且在停止药物输注后氧合恢复到基线水平。对于在与大出血相关的手术期间接受β受体阻滞剂治疗的患者,TOI可能有助于识别脑氧合的降低。